Related Experiment Video
Updated: Apr 3, 2026

Small-Scale Plasma Membrane Preparation for the Analysis of Candida albicans Cdr1-mGFPHis
Published on: June 13, 2021
The ABCs of Candida albicans Multidrug Transporter Cdr1
Rajendra Prasad1, Atanu Banerjee2, Nitesh Kumar Khandelwal2
1Institute of Integrative Sciences and Health and Institute of Biotechnology, Amity University Haryana, Amity Education Valley, Gurgaon, India Membrane Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India rprasad@ggn.amity.edu.
Abstract:
In the light of multidrug resistance (MDR) among pathogenic microbes and cancer cells, membrane transporters have gained profound clinical significance. Chemotherapeutic failure, by far, has been attributed mainly to the robust and diverse array of these proteins, which are omnipresent in every stratum of the living world. Candida albicans, one of the major fungal pathogens affecting immunocompromised patients, also develops MDR during the course of chemotherapy. The pivotal membrane transporters that C. albicans has exploited as one of the strategies to develop MDR belongs to either the ATP binding cassette (ABC) or the major facilitator superfamily (MFS) class of proteins. The ABC transporter Candida drug resistance 1 protein (Cdr1p) is a major player among these transporters that enables the pathogen to outplay the battery of antifungals encountered by it. The promiscuous Cdr1 protein fulfills the quintessential need of a model to study molecular mechanisms of multidrug transporter regulation and structure-function analyses of asymmetric ABC transporters. In this review, we cover the highlights of two decades of research on Cdr1p that has provided a platform to study its structure-function relationships and regulatory circuitry for a better understanding of MDR not only in yeast but also in other organisms.
Insights
Multidrug resistance (MDR) in Candida albicans is often mediated by membrane transporters like the ATP binding cassette (ABC) transporter Cdr1p. Research highlights Cdr1p
Area of Science:
- Microbiology
- Biochemistry
- Molecular Biology
Background:
- Multidrug resistance (MDR) in pathogenic microbes and cancer cells poses a significant clinical challenge.
- Membrane transporters, particularly ATP binding cassette (ABC) and major facilitator superfamily (MFS) proteins, are key mediators of MDR.
- Candida albicans, a major fungal pathogen, develops MDR through mechanisms involving these transporters, impacting antifungal chemotherapy.
Purpose of the Study:
- To review two decades of research on the Candida drug resistance 1 protein (Cdr1p).
- To elucidate the structure-function relationships and regulatory mechanisms of Cdr1p.
- To understand the role of Cdr1p in MDR in yeast and other organisms.
Main Methods:
- Literature review of studies on Cdr1p.
- Analysis of structure-function relationships of Cdr1p.
- Investigation of Cdr1p's regulatory circuitry.
Main Results:
- Cdr1p, an ABC transporter, is a major contributor to MDR in Candida albicans.
- Cdr1p exhibits promiscuity, enabling the pathogen to resist multiple antifungals.
- Two decades of research have established Cdr1p as a model for studying asymmetric ABC transporters.
Conclusions:
- Cdr1p is a critical determinant of MDR in Candida albicans.
- Understanding Cdr1p's mechanisms is vital for developing strategies against fungal infections.
- Cdr1p research provides insights applicable to MDR in diverse organisms.
Related Concept Videos
ABC Transporters: Exporter
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...

